INSTITUT CURIE
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1909-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.curie.fr
Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)
Not Applicable
Completed
- Conditions
- Uveal Melanoma
- Interventions
- Biological: Blood sampling
- First Posted Date
- 2016-07-29
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 60
- Registration Number
- NCT02849145
- Locations
- 🇫🇷
Institut Curie, Paris, France
Predictive Response to Chemotherapy (FOLFOX or FOLFIRI) by ex Vivo Culture 3D Technique in Metastatic Colorectal Cancer
Not Applicable
Completed
- Conditions
- Colorectal Cancer
- Interventions
- Procedure: biopsy to obtain a chemogram
- First Posted Date
- 2016-07-29
- Last Posted Date
- 2018-04-05
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 22
- Registration Number
- NCT02849106
- Locations
- 🇫🇷
Hôpital Lariboisière, Paris, France
🇫🇷Institut Curie, Paris, France
Fibroblast Before and After Neoadjuvant Chemo-radiotherapy in Patient With Locally Advanced Rectal Adenocarcinoma
Not Applicable
Completed
- Conditions
- Rectum Adenocarcinoma
- Interventions
- Other: Biopsy
- First Posted Date
- 2016-07-29
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 14
- Registration Number
- NCT02849158
- Locations
- 🇫🇷
Institut Curie, Paris, Ile De France, France
🇫🇷INSTITUT CURIE - Site Paris, Paris, France
🇫🇷Institut Curie - Hôpital René Huguenin, Saint-Cloud, Ile De France, France
Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy (Craniopharyngioma)
Phase 2
Completed
- Conditions
- Craniopharyngioma
- Interventions
- Radiation: Protontherapy
- First Posted Date
- 2016-07-25
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 33
- Registration Number
- NCT02842723
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, France
🇫🇷Groupe Hospitalier Necker Enfants Malades, Paris, France
🇫🇷Institut Curie, Paris, France
Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma
Phase 3
Completed
- Conditions
- Uveal Melanoma
- Interventions
- Other: Intensive surveillanceDrug: Adjuvant chemotherapy by Fotemustin
- First Posted Date
- 2016-07-25
- Last Posted Date
- 2022-08-31
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 302
- Registration Number
- NCT02843386
- Locations
- 🇫🇷
Centre Jean Perrin, Clermont-ferrand, France
🇫🇷Centre Léon Bérard, Lyon, France
🇫🇷CHU Nice, Nice, France
Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial
Phase 3
Completed
- Conditions
- Radiation DermatitisBreast Cancer
- Interventions
- Device: Hydrogel Hydrosorb®Device: Castalie water spray
- First Posted Date
- 2016-07-21
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 278
- Registration Number
- NCT02839473
- Locations
- 🇫🇷
Institut Curie, Paris, France
🇫🇷Centre René Huguenin, Saint Cloud, France
Assessment of Response to Neo-adjuvant Chemotherapy for Patients With a Locally Advanced Breast Cancer With 3D Elastography (Shear Wave),
Not Applicable
Completed
- Conditions
- Breast Neoplasms
- Interventions
- Procedure: 3D Shear Wave Elastography (SWE)Biological: Biopsy
- First Posted Date
- 2016-07-15
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 140
- Registration Number
- NCT02834494
- Locations
- 🇫🇷
Institut Curie Paris, Paris, France
A Feasibility Study to Identify T-cell Responses to Neo-epitopes in Tumor Invaded Lymph Nodes (NeoEpitope)
Not Applicable
Completed
- Conditions
- Cutaneous MelanomaBreast Cancer
- Interventions
- Procedure: Blood sampling
- First Posted Date
- 2016-07-13
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 25
- Registration Number
- NCT02831634
- Locations
- 🇫🇷
Institut Curie, Paris, France
Optimizing the Care Pathways of Patients Treated for Operable Breast.
Completed
- Conditions
- Breast CancerSurgery
- First Posted Date
- 2016-06-27
- Last Posted Date
- 2017-04-13
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 617
- Registration Number
- NCT02813317
- Locations
- 🇫🇷
René Dubos Hospital, Pontoise, France
🇫🇷Institut Curie - René Huguenin Hospital, Saint-Cloud, France
🇫🇷Victor Dupouy Hospital, Argenteuil, France
Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT Tracers
Phase 2
Completed
- Conditions
- Vertebral ChordomaSkull Base Chordoma
- Interventions
- Procedure: SurgeryRadiation: ProtontherapyDrug: 18F FAZA
- First Posted Date
- 2016-06-16
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 64
- Registration Number
- NCT02802969
- Locations
- 🇫🇷
Institut Curie - Hôpital René Huguenin, Saint-Cloud, Ile de France, France
© Copyright 2025. All Rights Reserved by MedPath